Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catheter Precision (VTAK) Liabilities and Shareholders Equity (2017 - 2025)

Catheter Precision (VTAK) has disclosed Liabilities and Shareholders Equity for 9 consecutive years, with $25.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Liabilities and Shareholders Equity fell 4.76% to $25.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $103.6 million, a 7.3% decrease, with the full-year FY2024 number at $27.8 million, down 9.65% from a year prior.
  • Liabilities and Shareholders Equity was $25.5 million for Q3 2025 at Catheter Precision, roughly flat from $25.6 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $48.5 million in Q1 2023 to a low of $16.8 million in Q4 2022.
  • A 5-year average of $27.4 million and a median of $26.5 million in 2024 define the central range for Liabilities and Shareholders Equity.
  • Peak YoY movement for Liabilities and Shareholders Equity: surged 104.27% in 2023, then crashed 42.24% in 2024.
  • Catheter Precision's Liabilities and Shareholders Equity stood at $21.0 million in 2021, then fell by 20.0% to $16.8 million in 2022, then skyrocketed by 82.56% to $30.7 million in 2023, then fell by 9.65% to $27.8 million in 2024, then decreased by 8.27% to $25.5 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Liabilities and Shareholders Equity are $25.5 million (Q3 2025), $25.6 million (Q2 2025), and $24.8 million (Q1 2025).